New Leaf Biopharma Opportunities II, L.P.'s Net Worth
$0
Who is New Leaf Biopharma Opportunities II, L.P.?
New Leaf Biopharma Opportunities II, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Principia Biopharma Inc., and Harpoon Therapeutics, Inc..
SEC CIK
New Leaf Biopharma Opportunities II, L.P.'s CIK is 0001735293
Past Insider Trading and Trends
2023 was New Leaf Biopharma Opportunities II, L.P.'s most active year for acquiring shares with 2 total transactions. New Leaf Biopharma Opportunities II, L.P.'s most active month to acquire stocks was the month of September. 2024 was New Leaf Biopharma Opportunities II, L.P.'s most active year for disposing of shares, totalling 3 transactions. New Leaf Biopharma Opportunities II, L.P.'s most active month to dispose stocks was the month of February. 2023 saw New Leaf Biopharma Opportunities II, L.P. paying a total of $0.00 for 2,058,000 shares, this is the most they've acquired in one year. In 2024 New Leaf Biopharma Opportunities II, L.P. cashed out on 1,772,816 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Principia Biopharma Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -11.43% | -300.00K |
$35.00 | -$10,500,000.00 | 2.33M |
Aug 13
| |||
Form 4
|
∞
| 2.63M |
$17.00 |
—
| 2.63M |
Sep 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Harpoon Therapeutics, Inc. (HARP) No price found
InvestorNew Leaf Biopharma Opportunities II, L.P. used to own units in Common Stock and 8.000% Series A Redeemable Preferred Stock but no longer holds any shares there. From 2019 to 2024 New Leaf Biopharma Opportunities II, L.P. acquired a total of 1,372,000 shares in Harpoon Therapeutics, Inc., New also disposed a total of 1,473,386 shares of Harpoon Therapeutics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.87M |
—
|
—
|
0
|
Mar 11
| |||
Form 4
| +488.96% | 1.54M |
—
|
—
| 1.86M |
Oct 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +34.68% | 235.29K |
$17.00 | $3,999,998.00 | 913.86K |
Jan 11
| |||
Form 4
| +117.19% | 2.92M |
$14.00 | $5,999,994.00 | 5.41M |
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||